Photo Release Samaritan Recognized for HIV Innovation
17th Nov 2006, 04:34 GMT
Samaritan Pharmaceuticals and Samaritan PharmaPlaz Ireland a developer of innovative drugs, announced it has been selected by the prestigious Frost & Sullivan Best Practices Group to receive the 2006 North American Technology Innovation Award, for its HIV Entry Inhibitor Drug Candidate SP-01A targeting HIV drug resistance.
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris